SCHEMBL443566

SCHEMBL443566

C1CCC(C[SiH2]C2CCCCO2)CC1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6355739 1.00 HPGD (0.31) HPGD
SCHEMBL12814193 1.00 HPGD (0.31) HPGD
SCHEMBL447072 0.98
SCHEMBL17239053 0.94
SCHEMBL159167 0.94
SCHEMBL17239041 0.92
SCHEMBL157438 0.92
SCHEMBL29168773 0.83
SCHEMBL2724024 0.79 TSHR (0.31)
SCHEMBL15845356 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9700495-B2 Method for making an emulsified antiperspirant product THE PROCTER & GAMBLE COMPANY (US) 2017-07-11 US claimed
US-20150366765-A1 Method For Making An Emulsified Antiperspirant Product PROCTER & GAMBLE (US) 2015-12-24 US claimed
EP-2203147-A2 SOLID ANTIPERSPIRANT COMPOSITION AND METHOD FOR MAKING SAME The Procter & Gamble Company (US) 2010-07-07 EP claimed
US-20090269292-A1 METHOD FOR MAKING AN EMULSIFIED ANTIPERSPIRANT PRODUCT THE PROCTER & GAMBLE COMPANY 2009-10-29 US claimed
US-20090202599-A1 SOLID ANTIPERSPIRANT COMPOSITION AND METHOD FOR MAKING SAME THE PROCTER & GAMBLE COMPANY 2009-08-13 US claimed
WO-2009044381-A2 SOLID ANTIPERSPIRANT COMPOSITION AND METHOD FOR MAKING SAME THE PROCTER & GAMBLE COMPANY (US) 2009-04-09 WO claimed
US-6464966-B1 CROSSLINKED ORGANOPOLYSILOXANE ELASTOMER COMPRISING A POLYOXYETHYLENATED CHAIN AND/OR A POLYOXYPROPYLENATED CHAIN L'OREAL (FR) 2002-10-15 US claimed
CN-117903696-A Water-based modified fluorosilicone resin coating composition, coating and preparation method thereof 东莞市雄驰电子有限公司 2024-04-19 CN disclosed
CN-117820646-A Amino silane ring-opened epoxy resin modified fluorosilicone resin aqueous emulsion, preparation method and application 东莞市雄驰电子有限公司 2024-04-05 CN disclosed
CN-105362092-B Antiperspirant or deodorant compositions 荷兰联合利华有限公司 2021-02-02 CN disclosed
US-9700495-B2 Method for making an emulsified antiperspirant product THE PROCTER & GAMBLE COMPANY (US) 2017-07-11 US disclosed
US-20150366765-A1 Method For Making An Emulsified Antiperspirant Product PROCTER & GAMBLE (US) 2015-12-24 US disclosed
US-20150307808-A1 Siloxane Traction Fluids with Ring-Shaped Branch Structures and Method of Using DOW SILICONES CORPORATION 2015-10-29 US disclosed
EP-1158951-A1 COSMETIC AGENT FOR REMOVAL OF A FILM FORMED BY CROSS-LINKED HYBRID MATERIAL L'OREAL (FR) 2001-12-05 EP disclosed
EP-0985402-B1 Stable w/o/w emulsion and its use for cosmetic and/or dermatologic composition OREAL (FR) 2001-08-29 EP disclosed
WO-2000053153-A1 COSMETIC AGENT FOR REMOVAL OF A FILM FORMED BY CROSS-LINKED HYBRID MATERIAL L'OREAL (FR) 2000-09-14 WO disclosed
EP-0985402-A1 Stable w/o/w emulsion and its use for cosmetic and/or dermatologic composition L'OREAL (FR) 2000-03-15 EP disclosed
EP-0075327-B1 TRACTION FLUIDS DOW CORNING CORPORATION (US) 1986-09-03 EP disclosed
US-4449415-A TRANSMISSION FLUIDS OF A MIXTURE OF ENDBLOCKED CARBOCYCLIC POLYSILOXANES AND CYCLOALIPHATIC HYDROCARBON; COLD RESISTANCE DOW CORNING CORPORATION (US) 1984-05-22 US disclosed
EP-0075327-A2 Traction fluids DOW CORNING CORPORATION (US) 1983-03-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090202599-A1 SOLID ANTIPERSPIRANT COMPOSITION AND METHOD FOR MAKING SAME PHOSPHO1, NAPEPLD, POLR1C HPGD 2473/4885
US-20150366765-A1 Method For Making An Emulsified Antiperspirant Product NAPEPLD, LIPA, CDIPT HPGD 313/4885
US-20090269292-A1 METHOD FOR MAKING AN EMULSIFIED ANTIPERSPIRANT PRODUCT NAPEPLD, LIPA, CDIPT HPGD 313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.